170 related articles for article (PubMed ID: 23032887)
41. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.
Sethi RV; Shih HA; Yeap BY; Mouw KW; Petersen R; Kim DY; Munzenrider JE; Grabowski E; Rodriguez-Galindo C; Yock TI; Tarbell NJ; Marcus KJ; Mukai S; MacDonald SM
Cancer; 2014 Jan; 120(1):126-33. PubMed ID: 24122173
[TBL] [Abstract][Full Text] [Related]
42. Does electron and proton therapy reduce the risk of radiation induced cancer after spinal irradiation for childhood medulloblastoma? A comparative treatment planning study.
Mu X; Björk-Eriksson T; Nill S; Oelfke U; Johansson KA; Gagliardi G; Johansson L; Karlsson M; Zackrisson DB
Acta Oncol; 2005; 44(6):554-62. PubMed ID: 16165914
[TBL] [Abstract][Full Text] [Related]
43. Controversies in clinical trials in proton radiotherapy: the present and the future.
Miller RC; Lodge M; Murad MH; Jones B
Semin Radiat Oncol; 2013 Apr; 23(2):127-33. PubMed ID: 23473690
[TBL] [Abstract][Full Text] [Related]
44. Carcinogenic effects of radiotherapy for breast cancer.
Neugut AI; Weinberg MD; Ahsan H; Rescigno J
Oncology (Williston Park); 1999 Sep; 13(9):1245-56; discussion 1257, 1261-5. PubMed ID: 10509322
[TBL] [Abstract][Full Text] [Related]
45. [Cancers after radiotherapy in children].
de Vathaire F
Bull Cancer; 1992; 79(4):379-82. PubMed ID: 1421699
[No Abstract] [Full Text] [Related]
46. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
Kaufman EL; Jacobson JS; Hershman DL; Desai M; Neugut AI
J Clin Oncol; 2008 Jan; 26(3):392-8. PubMed ID: 18202415
[TBL] [Abstract][Full Text] [Related]
47. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
48. Clinical controversies: proton therapy for thoracic tumors.
De Ruysscher D; Chang JY
Semin Radiat Oncol; 2013 Apr; 23(2):115-9. PubMed ID: 23473688
[TBL] [Abstract][Full Text] [Related]
49. Mapping radiation quality inside photon-irradiated absorbers by means of a twin-chamber method.
Chofor N; Harder D; Looe HK; Kapsch RP; Kollhoff R; Willborn K; Rühmann A; Poppe B
Z Med Phys; 2009; 19(4):252-63. PubMed ID: 19962083
[TBL] [Abstract][Full Text] [Related]
50. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
[TBL] [Abstract][Full Text] [Related]
51. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
52. Intracranial tumours after external fractionated radiotherapy for pituitary adenomas in northern Sweden.
Norberg L; Johansson R; Rasmuson T
Acta Oncol; 2010 Nov; 49(8):1276-82. PubMed ID: 20429723
[TBL] [Abstract][Full Text] [Related]
53. Induced second cancers after prostate-cancer radiotherapy: no cause for concern?
Brenner DJ
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):637-9. PubMed ID: 16751057
[No Abstract] [Full Text] [Related]
54. [Late sequelae of oncologic treatment in children].
Heikens J; Somers R; Behrendt H; Oldenburger F; Langeveld NE; Bakker PJ
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2191-5. PubMed ID: 9864480
[TBL] [Abstract][Full Text] [Related]
55. In regards to Hall: intensity-modulated radiation therapy, protons, and the risk of second cancers (Int J Radiat Oncol Biol Phys 2006;65:1-7).
Macklis R
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1593-4; author reply 1595. PubMed ID: 17126216
[No Abstract] [Full Text] [Related]
56. Physics controversies in proton therapy.
Engelsman M; Schwarz M; Dong L
Semin Radiat Oncol; 2013 Apr; 23(2):88-96. PubMed ID: 23473685
[TBL] [Abstract][Full Text] [Related]
57. Second malignant neoplasms following radiotherapy.
Kumar S
Int J Environ Res Public Health; 2012 Dec; 9(12):4744-59. PubMed ID: 23249860
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic radiation and the potential risk of second malignancies.
Kamran SC; Berrington de Gonzalez A; Ng A; Haas-Kogan D; Viswanathan AN
Cancer; 2016 Jun; 122(12):1809-21. PubMed ID: 26950597
[TBL] [Abstract][Full Text] [Related]
59. Second malignant neoplasms and cardiovascular disease following radiotherapy.
Travis LB; Ng AK; Allan JM; Pui CH; Kennedy AR; Xu XG; Purdy JA; Applegate K; Yahalom J; Constine LS; Gilbert ES; Boice JD
Health Phys; 2014 Feb; 106(2):229-46. PubMed ID: 24378498
[TBL] [Abstract][Full Text] [Related]
60. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
Tseng YD; Cutter DJ; Plastaras JP; Parikh RR; Cahlon O; Chuong MD; Dedeckova K; Khan MK; Lin SY; McGee LA; Shen EY; Terezakis SA; Badiyan SN; Kirova YM; Hoppe RT; Mendenhall NP; Pankuch M; Flampouri S; Ricardi U; Hoppe BS
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):825-842. PubMed ID: 28943076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
